Carnival Corporation-owned ships offer more convenient pre-board COVID testing

   September 10, 2021 ,   Cruise Industry

The world's largest cruise shipowner Carnival Corporation announced a new initiative that is making pre-board testing more accessible and convenient for its customers.

The effort facilitates access to pre-cruise COVID viral testing for passengers of the Corporation's subsidiaries CCL-Carnival Cruise Line, HAL-Holland America Line, Princess and Seabourn at 1500+ convenient Quest Diagnostics patient service centers and retail pharmacy testing locations throughout the USA.

The program streamlines pre-cruise preparation for passengers planning to sail aboard Carnival, HAL, Princess, or Seabourn.

Currently, all passengers, regardless of their vaccination status, must present a negative COVID viral test taken no more than 3 days before embarkation, along with additional health & safety requirements.

Beginning September 13 and after, in accordance with CDC directives, all vaccinated passengers must present a negative COVID viral test taken no more than 2 days before embarkation.

The pre-board test (molecular/antigen) is one of the added measures implemented by the company’s lines.

Vacationers may schedule testing with Quest Diagnostics at 1500+ locations, including Quest Diagnostics patient service centers and select Walmart and other retail pharmacies throughout the United States.

Results are typically available within 48 hours via email/mobile application.

Your personal data will be processed and information from your device (cookies, unique identifiers, and other device data) may be stored by, accessed by and shared with third party vendors, or used specifically by this site or app. Some vendors may process your personal data on the basis of legitimate interest, which you can object to by managing your options below. Look for a link at the bottom of this page or in our privacy policy where you can withdraw consent.